Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Upendra Parvathaneni, MBBS"'
Autor:
Marika M. Bierma, BS, BA, Peter H. Goff, MD, PhD, Daniel S. Hippe, MS, Kristina Lachance, MS, Stephanie K. Schaub, MD, Kent Wallner, MD, Yolanda D. Tseng, MD, Jay J. Liao, MD, Smith Apisarnthanarax, MD, Paul Nghiem, MD, PhD, Upendra Parvathaneni, MBBS, FRANZCR
Publikováno v:
Advances in Radiation Oncology, Vol 9, Iss 2, Pp 101364- (2024)
Purpose: The role of postoperative radiation therapy (PORT) in early stage Merkel cell carcinoma (MCC) is controversial. We analyzed the role of PORT in preventing local recurrences (LR) among patients with low-risk, pathologic stage I MCC based on t
Externí odkaz:
https://doaj.org/article/f76692e20b5b4fc791dc49fc6bf08c9d
Autor:
Chieko Michikawa, DDS, PhD, Pedro A. Torres-Saavedra, PhD, Natalie L. Silver, MD, MS, Paul M. Harari, MD, Merrill S. Kies, MD, David I. Rosenthal, MD, Quynh-Thu Le, MD, Richard C. Jordan, DDS, PhD, Dzifa Y. Duose, PhD, Saradhi Mallampati, DVM, PhD, Sanchit Trivedi, MS, Rajyalakshmi Luthra, PhD, Ignacio I. Wistuba, MD, Abdullah A. Osman, PhD, Olivier Lichtarge, MD, PhD, Robert L. Foote, MD, Upendra Parvathaneni, MBBS, D. Neil Hayes, MD, MPH, Curtis R. Pickering, PhD, Jeffrey N. Myers, MD, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 7, Iss 6, Pp 100989- (2022)
Purpose: An evolutionary action scoring algorithm (EAp53) based on phylogenetic sequence variations stratifies patients with head and neck squamous cell carcinoma (HNSCC) bearing TP53 missense mutations as high-risk, associated with poor outcomes, or
Externí odkaz:
https://doaj.org/article/af4a399b5e144a18b46cb1524d746ef0
Autor:
Alexander Lin, MD, John H. C. Chang, MD, Ryan S. Grover, MD, Frank J. P. Hoebers, MD, PhD, Upendra Parvathaneni, MBBS, FRANZCR, Samir H. Patel, MD, Juliette Thariat, MD, PhD, David J. Thomson, MA, MD, FACR, Johannes A. Langendijk, MD, PhD, Steven J. Frank, MD, on behalf of the International Particle Therapy Co-operative Group (PTCOG) Head and Neck Subcommittee
Publikováno v:
International Journal of Particle Therapy, Vol 8, Iss 1, Pp 84-94 (2021)
Purpose: Radiation therapy is a standard modality in the treatment for cancers of the head and neck, but is associated with significant short- and long-term side effects. Proton therapy, with its unique physical characteristics, can deliver less dose
Externí odkaz:
https://doaj.org/article/fc4a855df70048c59dc3bb7213149998
Intensity-Modulated Proton Therapy for Nasopharynx Cancer: 2-year Outcomes from a Single Institution
Autor:
Vonetta M. Williams, MD, PhD, Upendra Parvathaneni, MBBS, FRANZCR, George E. Laramore, PhD, MD, Saif Aljabab, MBBS, FRCPC, Tony P. Wong, PhD, Jay J. Liao, MD
Publikováno v:
International Journal of Particle Therapy, Vol 8, Iss 2, Pp 28-40 (2021)
Purpose: Advances in radiotherapy have improved tumor control and reduced toxicity in the management of nasopharyngeal carcinoma (NPC). Local failure remains a problem for some patients with advanced primary tumors, and toxicities are significant giv
Externí odkaz:
https://doaj.org/article/c2da7a68a072433a94889bddbed5c576
Autor:
Peter H. Goff, MD, PhD, Stephanie K. Schaub, MD, Maclean M. Cook, BS, Paul N. Nghiem, MD, PhD, Upendra Parvathaneni, MBBS, FRANZCR
Publikováno v:
Advances in Radiation Oncology, Vol 6, Iss 3, Pp 100685- (2021)
Externí odkaz:
https://doaj.org/article/d6790b1364de40b383a8c73e4ffc5333
Autor:
Seesha R. Takagishi, BS, Tessa E. Marx, BS, Christopher Lewis, BS, Erica S. Tarabadkar, MD, Ilsa D. Juhlin, Astrid Blom, MD, Jayasri G. Iyer, MD, Jay J. Liao, MD, Yolanda D. Tseng, MD MPhil, Teresa Fu, MD, Paul Nghiem, MD PhD, Upendra Parvathaneni, MBBS FRANZCR
Publikováno v:
Advances in Radiation Oncology, Vol 1, Iss 4, Pp 244-251 (2016)
Purpose: Merkel cell carcinoma (MCC) is a rare and often aggressive skin cancer. Typically, surgery is the primary treatment. Postoperative radiation therapy (PORT) is often recommended to improve local control. It is unclear whether PORT is indicate
Externí odkaz:
https://doaj.org/article/bc63418920f4444db2973fe1ae43ea79